Results 161 to 170 of about 1,971,842 (244)

Immune‐related adverse events with mogamulizumab in cutaneous T‐cell lymphoma: A multicentre study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In a nationwide multicentre study of 403 patients with cutaneous T‐cell lymphoma treated with mogamulizumab, non‐MAR immune‐related adverse events were reported in 8.4% of patients across responding centres. These events were diverse, sometimes severe or persistent, and could occur late during mogamulizumab treatment.
David Neubauer   +28 more
wiley   +1 more source

Oral Site-Specific Patch Testing Directly at the Fixed Drug Eruption Site in Drug Allergy Investigation. [PDF]

open access: yesContact Dermatitis
Chumsaengchotsakul C   +3 more
europepmc   +1 more source

Integrating Pharmacogenomic Testing Within the 4Ms Framework for Management of Behavioral Symptoms in Advanced Vascular Dementia: A Case Study

open access: yesJournal of the American Geriatrics Society, EarlyView.
Pharmacogenomic‐guided managment of behavioral symptoms within the 4Ms framework.
Gianna Franco   +3 more
wiley   +1 more source

A Rare Case of Leprosy in Sweden Mimicking Drug Eruption. [PDF]

open access: yesActa Derm Venereol
Alvergren G   +3 more
europepmc   +1 more source

Orofacial Myofunctional Therapy for Feeding and Swallowing in Children From Four to 12 Years: What Does the Evidence Show? A Systematic Review

open access: yesJournal of Oral Rehabilitation, EarlyView.
This systematic review evaluated the effectiveness of orofacial myofunctional therapy (OMT) for improving feeding and swallowing outcomes in children aged 4–12 years. Searches of four databases identified 17 studies, all reporting positive feeding and/or swallowing outcomes, including improved eating and swallowing skills, orofacial muscle function and
Danielle Carey   +6 more
wiley   +1 more source

CHARGE Syndrome: A Narrative Review and Update on Diagnosis, Assessment and Management

open access: yesJournal of Paediatrics and Child Health, EarlyView.
ABSTRACT Background CHARGE syndrome (CS) is a rare multisystemic genetic condition caused by a pathogenic variant in the DNA‐binding protein‐7 CHD7 gene. The condition affects the development of neural crest cells, which give rise to craniofacial structures, cranial nerves, ears, eyes and the heart, resulting in diverse and complex clinical features ...
Eleni M. van Gelder   +7 more
wiley   +1 more source

Cell Therapy for Periodontal, Soft‐Tissue, and Craniofacial Regeneration

open access: yesJournal of Periodontal Research, EarlyView.
The clinical translation of mesenchymal stem/stromal cells (MSCs) represents a major advancement in dentistry, especially for periodontal, soft‐tissue, and craniofacial regeneration. However, several challenges remain to be addressed, including the absence of standardised protocols, limited scalability, regulatory hurdles, a lack of well‐controlled ...
Kamal Mustafa   +5 more
wiley   +1 more source

Psoriasiform Drug Eruption following Fremanezumab: A Case Report. [PDF]

open access: yesCase Rep Dermatol
Coffman K   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy